The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.The pharmaceutical industry is witnessing something of a renaissance right now. Just a couple of years ago, drug companies banded together and created multiple vaccine treatments used to combat COVID-19.While these breakthrough medications captivated the minds of investors, new growth opportunities have emerged in other areas. In particular, weight loss treatments used for diabete ...